BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38301422)

  • 1. Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
    Elghetany MT; Patnaik MM; Khoury JD
    Leuk Res; 2024 Feb; 137():107441. PubMed ID: 38301422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.
    Savage SA; Dufour C
    Semin Hematol; 2017 Apr; 54(2):105-114. PubMed ID: 28637614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
    Schaefer EJ; Lindsley RC
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):643-655. PubMed ID: 30047417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow cell cycle markers in inherited bone marrow failure syndromes.
    Al-Rahawan MM; Alter BP; Bryant BJ; Elghetany MT
    Leuk Res; 2008 Dec; 32(12):1793-9. PubMed ID: 18606449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer predisposition in inherited bone marrow failure syndromes and primary immunodeficiency diseases].
    Ishimura M; Ohga S
    Rinsho Ketsueki; 2019; 60(6):702-707. PubMed ID: 31281163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
    Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited bone marrow failure syndromes and germline predisposition to myeloid neoplasia: A practical approach for the pathologist.
    Li J; Bledsoe JR
    Semin Diagn Pathol; 2023 Nov; 40(6):429-442. PubMed ID: 37507252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Predispositions to Myelodysplastic Syndrome.
    Bannon SA; DiNardo CD
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27248996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline GATA2 Mutation and Bone Marrow Failure.
    McReynolds LJ; Calvo KR; Holland SM
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to Acquired and Inherited Bone Marrow Failure.
    Sieff CA
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
    Schratz KE; DeZern AE
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):333-356. PubMed ID: 32089214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
    Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monosomy 7/del (7q) in inherited bone marrow failure syndromes: A systematic review.
    Pezeshki A; Podder S; Kamel R; Corey SJ
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28708320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Myelodysplastic Syndromes.
    Patel SS
    Clin Lab Med; 2021 Sep; 41(3):517-528. PubMed ID: 34304779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
    Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.